PillRx only · Tablet · Oral
Carbinoxamine Maleate
Brands: Ryvent · Carbinoxamine Maleate
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.992
Latest avg · Jul 22, 2026
-63%
Since Feb 14, 2025
6
Active US suppliers
43%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.4K
Rx · 2026 Q1
151K
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Carwin Pharmaceutical Associates, LLC | unknown | 2 | SUPPLYING |
| BluCrest Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Genus Lifesciences | unknown | 1 | SUPPLYING |
| Leading Pharma, LLC | unknown | 1 | SUPPLYING |
| BioComp Pharma, Inc. | unknown | 1 | SUPPLYING |
| TRIPOINT THERAPEUTICS, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.